Journal Article Ppublish 1 citation
PubMed: 41874280 DOI: 10.1093/ejhf/xuag049
The effect of vericiguat on sudden cardiac death: insights from the VICTOR trial.
Eur J Heart Fail 28(3):437-443
Authors: Francesco Fioretti, Faiez Zannad, Irina Barash, Stefano Corda, Justin A Ezekowitz, Carolyn S P Lam, Robert J Mentz, Christopher M O'Connor, Inga Bayh, Aiwen Xing, Javed Butler
Affiliations
- Baylor Scott and White Research Institute, 3434 Live Oak St Ste 501, Dallas, TX 75204, USA.
- CVCT and Universite de Lorraine, Nancy, France.
- Merck & Co. Inc. Rahway, NJ, USA.
- Bayer AG, Basel, Switzerland.
- Canadian VIGOUR Centre, University of Alberta, Edmonton, AB, Canada.
- National Heart Centre Singapore and Duke-National University of Singapore, Singapore, Singapore.
- Duke Clinical Research Institute, Durham, NC, USA.
- Inova Heart and Vascular Institute, Falls Church, VA, USA.
- Department of Medicine, University of Mississippi, Jackson, MS, USA.
MeSH
Heart Failure, Death, Sudden, Cardiac